Table 1.
Mesoporous Phase | Matrix | Processing | Effect | References |
---|---|---|---|---|
MBG | Collagen | Mixing | Improved bioactivity in vitro and mechanical properties | [17] |
Sol-gel glass | PLLA | Solid–liquid phase separation + solvent extraction | Improved bioactivity in vitro | [18] |
MBG | PLGA | Mixing | Improved bioactivity in vitro, drug release | [19,22] |
MBG | Polyamide | Solvent casting/particulate leaching | Improved bioactivity in vitro and bone regeneration in vivo | [23] |
MBG | PCL | Solvent casting/particulate leaching | Improved bioactivity in vitro, drug release | [20] |
Robocasting + salt leaching | Improved bioactivity in vitro and mechanical properties, pliability | [24] | ||
MBG | Alginate | Mixing | Improved bioactivity in vitro, drug release | [21] |
3D plotting | Improved bioactivity in vitro, drug release | [25] | ||
MBG | Silk fibroin | Freeze-drying | Improved bioactivity in vitro and mechanical properties | [26,27] |
MBG | Calcium phosphate | Mixing + freeze-drying | Adequate mechanical properties and bone regeneration in vivo | [28] |
MBG | Chitosan | Freeze-drying | Hemostasis to promote wound healing | [29] |
MBG: mesoporous bioactive glasses; PLLA: poly(L-lactic acid); PLGA: poly(lactic-co-glycolic acid); PCL: poly(caprolactone).